DMKPQ Company Profile DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company’s lead clinical stage product candidate, DPI-125, which is in...
DMKPQ 0.000001 0.00% DMK Pharmaceuticals Corporation BLCM 0 0.00% Bellicum Pharmaceuticals, Inc. Compare Similar to BXRXQ SymbolLast PriceChange CYTOF 0.10 13.64% Altamira Therapeutics Ltd. VRPXVirpax Pharmaceuticals, Inc. 0.33 Post. 0.30 12.95% ...